Characterization of Laryngeal Contact Granulomas: Retrospective Analysis of Symptoms, Promotive Factors and Therapy

Laryngeal Contact Granuloma Clinical Trial

Official title:

Characterization of Laryngeal Contact Granulomas: Retrospective Analysis of Symptoms, Promotive Factors and Therapy

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01967693
• Other study ID #: BJ_04_04_2012
• Status: Completed
• Phase: N/A
• First received: September 18, 2013
• Last updated: May 13, 2016
• Start date: March 2008
• Est. completion date: August 2013

Study information

• Verified date: May 2016
• Source: University of Zurich
• Contact: n/a
• Is FDA regulated: No
• Health authority: Switzerland: Swissmedic
• Study type: Observational

Clinical Trial Summary

Retrospective analysis of data from patients with laryngeal contact granulomas in order to identify possible differences and/or similarities between the cases and in order to determine whether and which conclusions can be drawn on disease and therapy.

Description:

This is a retrospective analysis of data from patients with laryngeal contact granulomas in order to identify possible differences and/or similarities between the cases and in order to determine whether and which conclusions can be drawn on disease and therapy.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 42
• Est. completion date: August 2013
• Est. primary completion date: August 2012
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 90 Years

Eligibility

Inclusion criteria:

Laryngeal contact granuloma in adults with documentation of symptoms, possible causes, therapy and outcome

Exclusion criteria:

Incomplete information on the diagnosis laryngeal contact granuloma (symptoms, promotive factors, findings)

Study Design

Observational Model: Case-Only, Time Perspective: Retrospective

Related Conditions & MeSH terms

• Granuloma
• Laryngeal Contact Granuloma

Intervention

Procedure:
• Retrospective analysis of data
Retrospective data analysis

Locations

Country	Name	City	State
Switzerland	University Hospital Zurich, Division of Otorhinolaryngology	Zurich	ZH

Sponsors (1)

Lead Sponsor	Collaborator
University of Zurich

Country where clinical trial is conducted

Switzerland, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Percentage of patients with similar therapy outcome as a measure of therapy predictability	Data from patients with laryngeal contact granuloma are analyzed retrospectively as to wether similar pathologies and treatment lead to similar outcome.	4 to 6 months after finishing the therapy	No